Hematopoietic Stem Cell Transplant (HSCT): Clinical Trials

8 trials for Hematopoietic Stem Cell Transplant (HSCT), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 1 active not recruiting, 1 completed, 1 terminated. 8 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Recruiting 4, Active not recruiting 1, Completed 1, Terminated 1, Unknown 1
Phase 11Recruiting 1

Follow Hematopoietic Stem Cell Transplant (HSCT): new trials by email Literature Review of Hematopoietic Stem Cell Transplant (HSCT) trials Research Report on Hematopoietic Stem Cell Transplant (HSCT)

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Venetoclax Combined With Azacitidine for Consolidation Therapy in AML
Ara-C Group, VEN/AZA condsolidation - Acute Myeloid Leukemia, Consolidation Therapy
Phase 2RecruitingThe First Affiliated Hospital of Soochow University2162026-02-012026-08-06
Ivosidenib as Post-HSCT Maintenance for AML
Ivosidenib, Placebo - IDH1 Mutation, Acute Myeloid Leukemia (AML)
Phase 2RecruitingMassachusetts General Hospital752026-01-162026-10-05
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
PUL-042, Placebo - Hematologic Malignancies, Hematopoietic Stem Cell Transplant (HSCT)
Phase 2RecruitingPulmotect, Inc.1002025-06-272026-08-04
Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients
SWA (standardized root extract of Withania somnifera) - Hematopoietic Stem Cell Transplant (HSCT), GVHD - Graft-Versus-Host Disease
Phase 1 / Phase 2RecruitingTata Memorial Centre542025-01-282026-07-24
Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia
Fludarabine + Treosulfan - Acute Myeloid Leukaemia (AML), Hematopoietic Stem Cell Transplant (HSCT)
Phase 2Active not recruitingAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia822022-11-102025-11-18
Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant
Ruxolitinib - Hematopoietic Stem Cell Transplant (HSCT), Bronchiolitis Obliterans (BO)
Phase 2TerminatedChildren's Hospital Medical Center, Cincinnati72021-11-122026-04-07
Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation
N-acetylcysteine, Placebo - Sinusoidal Obstruction Syndrome (SOS), Hematopoietic Stem Cell Transplant (HSCT)
Phase 2UnknownInstituto Brasileiro de Controle do Cancer802021-04-012021-03-09
Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS
Reduced-Intensity Conditioning Regimen, Myeloablative Conditioning Regimen - Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)
Phase 2CompletedRandy Windreich212015-09-042024-07-16

Narrower conditions

Leukemia, Myeloid, Acute (4)  ·  Hematologic Neoplasms (2)  ·  Bronchiolitis Obliterans (1)  ·  Graft vs Host Disease (1)  ·  Hepatic Veno-Occlusive Disease (1)  ·  Myelodysplastic Syndromes (1)

Broader conditions

Hematologic Diseases (6)  ·  Hemic and Lymphatic Diseases (6)  ·  Neoplasms (6)  ·  Leukemia (4)  ·  Leukemia, Myeloid (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms by Site (2)  ·  Bone Marrow Diseases (1)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchitis (1)  ·  Cardiovascular Diseases (1)  ·  Digestive System Diseases (1)  ·  Immune System Diseases (1)  ·  Liver Diseases (1)

Interventions

Acetylcysteine (1)  ·  Alemtuzumab (1)  ·  Busulfan (1)  ·  Hydroxyurea (1)  ·  Melphalan (1)  ·  Pam2CSK4 acetate and ODN M362 combination (1)  ·  Thiotepa (1)  ·  fludarabine (1)  ·  fludarabine phosphate (1)  ·  ivosidenib (1)  ·  ruxolitinib (1)  ·  treosulfan (1)

Sponsors

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Instituto Brasileiro de Controle do Cancer (1)  ·  Massachusetts General Hospital (1)  ·  Pulmotect, Inc. (1)  ·  Randy Windreich (1)  ·  Tata Memorial Centre (1)  ·  The First Affiliated Hospital of Soochow University (1)

Countries

United States (4)  ·  Brazil (1)  ·  China (1)  ·  India (1)  ·  Italy (1)

Top investigators

Amir T Fathi, MD (1)  ·  Colin Broom, MD (1)  ·  Domenico Russo, MD (1)  ·  Jamilla N Cavalcante, MD (1)  ·  Kasiani Myers, MD (1)  ·  Randy Windreich, MD (1)

Results publications

PMID 10845900, PMID 11034090, PMID 12651206, PMID 12663454, PMID 18246351, PMID 18997826, PMID 19282026, PMID 21478921, PMID 21659356, PMID 22158386, PMID 22410750, PMID 22754076, PMID 22982675, PMID 23802653, PMID 25452693, PMID 26408225, PMID 26429297, PMID 26959007, PMID 27250656, PMID 29247780, PMID 29318584, PMID 29557088, PMID 30904387, PMID 31606445, PMID 31678539, PMID 32160294, PMID 32416453, PMID 32537114, PMID 32684166, PMID 33574236, PMID 34204308, PMID 3513012, PMID 36518386, PMID 38485149, PMID 5449164, PMID 9746768